DK1645566T3 - Parathyroidhormonanaloger - Google Patents

Parathyroidhormonanaloger

Info

Publication number
DK1645566T3
DK1645566T3 DK05026436.5T DK05026436T DK1645566T3 DK 1645566 T3 DK1645566 T3 DK 1645566T3 DK 05026436 T DK05026436 T DK 05026436T DK 1645566 T3 DK1645566 T3 DK 1645566T3
Authority
DK
Denmark
Prior art keywords
parathyroid hormone
hormone analogues
analogues
pthrp
pth
Prior art date
Application number
DK05026436.5T
Other languages
English (en)
Inventor
Zheng Xin Dong
Original Assignee
Ipsen Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/779,768 external-priority patent/US5969095A/en
Application filed by Ipsen Pharma filed Critical Ipsen Pharma
Application granted granted Critical
Publication of DK1645566T3 publication Critical patent/DK1645566T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/635Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK05026436.5T 1997-01-07 1997-12-08 Parathyroidhormonanaloger DK1645566T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/779,768 US5969095A (en) 1995-07-13 1997-01-07 Analogs of parathyroid hormone
US08/813,534 US5955574A (en) 1995-07-13 1997-03-07 Analogs of parathyroid hormone
EP97951595A EP0948541B1 (en) 1997-01-07 1997-12-08 Analogs of PTHrP

Publications (1)

Publication Number Publication Date
DK1645566T3 true DK1645566T3 (da) 2010-09-27

Family

ID=27119618

Family Applications (2)

Application Number Title Priority Date Filing Date
DK97951595T DK0948541T3 (da) 1997-01-07 1997-12-08 Analoge af PTHrP
DK05026436.5T DK1645566T3 (da) 1997-01-07 1997-12-08 Parathyroidhormonanaloger

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK97951595T DK0948541T3 (da) 1997-01-07 1997-12-08 Analoge af PTHrP

Country Status (24)

Country Link
US (1) US5955574A (da)
EP (3) EP0948541B1 (da)
JP (1) JP3963482B2 (da)
KR (2) KR100699422B1 (da)
CN (1) CN1137898C (da)
AR (3) AR011517A1 (da)
AT (2) ATE321784T1 (da)
AU (1) AU741584B2 (da)
BR (1) BR9714200A (da)
CA (1) CA2276614C (da)
CZ (2) CZ298937B6 (da)
DE (2) DE69735603T2 (da)
DK (2) DK0948541T3 (da)
ES (2) ES2347154T3 (da)
HK (1) HK1026215A1 (da)
HU (1) HUP9904596A3 (da)
IL (1) IL130794A0 (da)
NO (1) NO993341L (da)
NZ (1) NZ336610A (da)
PL (1) PL191898B1 (da)
PT (2) PT1645566E (da)
RU (1) RU2198182C2 (da)
SI (2) SI0948541T1 (da)
WO (1) WO1998030590A2 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7410948B2 (en) * 1995-07-13 2008-08-12 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Analogs of parathyroid hormone
US6544949B1 (en) * 1995-07-13 2003-04-08 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Analogs of parathyroid hormone
RS49707B (sr) * 1997-09-09 2007-12-31 F.Hoffmann-La Roche Ag., Primena polipeptidnog analoga peptida srodnog paratireoidnom hormonu i njegovih soli za proizvodnju medikamenata za lečenje preloma kostiju
AU3673699A (en) * 1998-05-05 1999-11-23 Beth Israel Deaconess Medical Center Pth2 receptor selective compounds
PL345583A1 (en) * 1998-07-20 2001-12-17 Sod Conseils Rech Applic Peptide analogues of pacap
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
WO2001060862A1 (en) * 2000-02-18 2001-08-23 Dabur Research Foundation Vasoactive intestinal peptide analogs
US6756480B2 (en) * 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US20050124537A1 (en) * 2000-04-27 2005-06-09 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
BRPI0209748B1 (pt) 2001-06-01 2015-11-24 Novartis Ag composição farmacêutica para administração oral compreendendo hormonio paratireoide(pth), e seu uso
US7572765B2 (en) 2001-07-23 2009-08-11 The General Hospital Corporation Conformationally constrained parathyroid hormone (PTH) analogs
MXPA06001428A (es) * 2003-08-06 2006-05-15 Rhodia Metodo para promover el crecimiento del hueso.
CN101355959B (zh) 2005-11-10 2013-02-27 密歇根理工大学管理委员会 黑熊甲状旁腺素和使用黑熊甲状旁腺素的方法
US7803770B2 (en) 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
PT2957278T (pt) * 2006-10-03 2017-08-23 Ipsen Pharma Sas Uma composição estável compreendendo pthrp e utilizações da mesma
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
WO2008048784A1 (en) * 2006-10-13 2008-04-24 Eli Lilly And Company Pegylated pth as pth receptor modulators and uses thereof
BRPI0814962B8 (pt) 2007-08-01 2021-05-25 Chugai Pharmaceutical Co Ltd métodos in vitro para determinar se um composto candidato é um agonista de longa duração ou de curta duração de um receptor acoplado à proteína g, polipeptídeo, seu uso e composição farmacêutica
CN102448482A (zh) 2009-03-27 2012-05-09 范安德尔研究所 甲状旁腺素肽和甲状旁腺素相关蛋白肽及使用方法
CA2782640A1 (en) 2009-12-07 2011-06-16 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
ME02474B (me) 2010-05-12 2017-02-20 Radius Health Inc Terapijski režimi
JP5941040B2 (ja) 2010-05-13 2016-06-29 ザ ジェネラル ホスピタル コーポレイション 副甲状腺ホルモン類似体およびその使用
BR112013007685B1 (pt) 2010-09-28 2021-11-09 Radius Pharmaceuticals, Inc Compostos moduladores de receptor andrógeno seletivos, composição farmacêutica compreendendo os referidos compostos, método de identificação de um composto capaz de modular um receptor andrógeno, usos de um composto ou da composição e processo para a preparação de um composto
IL297369B1 (en) 2015-04-29 2024-02-01 Radius Pharmaceuticals Inc RAD for use in a method to treat mutant estrogen receptor positive breast cancer or mutant estrogen receptor positive ovarian cancer
US20180161401A1 (en) * 2015-07-06 2018-06-14 Zheng Xin Dong Novel Formulations of PTHrP Analogue
RU2769527C2 (ru) 2016-06-22 2022-04-01 Эллипсес Фарма Лтд Способы лечения ar+ рака молочной железы
KR102322802B1 (ko) 2017-01-05 2021-11-04 래디어스 파마슈티컬스, 인코포레이티드 Rad1901-2hcl의 다형 형태
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
US11643385B2 (en) 2018-07-04 2023-05-09 Radius Pharmaceuticals, Inc. Polymorphic forms of RAD1901-2HCl

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
FR2550204B1 (fr) * 1983-08-05 1987-11-13 Toyo Jozo Kk Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
EP0293158A3 (en) * 1987-05-26 1990-05-09 Merck & Co. Inc. Parathyroid hormone antagonists
WO1990010067A1 (de) * 1989-02-23 1990-09-07 GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) Pth-varianten kodierende dna-sequenzen, pth-varianten, expressionsvektor, bakterieller wirt, verwendung und therapeutische zusammensetzung
CA2040264A1 (en) * 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
AU2807892A (en) * 1991-10-10 1993-05-03 Peter K.T. Pang Parathyroid hormone analogues and use in osteoporosis treatment
US5434246A (en) * 1992-03-19 1995-07-18 Takeda Chemical Industries, Ltd. Parathyroid hormone derivatives
CA2098639A1 (en) * 1992-06-19 1993-12-20 K. Anne Kronis Bone stimulating, non-vasoactive parathyroid hormone variants
US5821225A (en) * 1992-07-14 1998-10-13 Syntex (U.S.A.) Inc. Method for the treatment of corticosteroid induced osteopenia comprising administration of modified PTH or PTHrp
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
HU220137B (hu) 1993-01-06 2001-11-28 Kinerton Ltd. Biológiailag lebontható poliészterek és biológiailag aktív polipeptidek ionos molekuláris konjugátumai, eljárás ezek előállítására és eljárás mikrorészecskék előállítására
CN1070500C (zh) * 1993-07-13 2001-09-05 森德克斯(美国)股份有限公司 甲状旁腺激素类似物和甲状旁腺激素相关肽:合成和治疗骨质疏松症的用途
EP0800405A4 (en) * 1994-12-19 1998-11-11 Beth Israel Hospital CONTINUOUS ADMINISTRATION OF LOW DOSES OF HORMONE PARATHYRO DIENNE OR ITS AGONIST
CA2178894A1 (en) * 1995-06-15 1996-12-16 Tsunehiko Fukuda Parathyroid hormone derivatives and their use
US5723577A (en) * 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone

Also Published As

Publication number Publication date
CZ298937B6 (cs) 2008-03-19
ES2347154T3 (es) 2010-10-26
AU5519998A (en) 1998-08-03
NO993341L (no) 1999-09-06
CZ239899A3 (cs) 2000-01-12
SI1645566T1 (sl) 2010-11-30
PT948541E (pt) 2006-07-31
DE69735603T2 (de) 2006-11-30
EP1645566B1 (en) 2010-06-16
NZ336610A (en) 2001-07-27
KR100699422B1 (ko) 2007-03-28
PL334438A1 (en) 2000-02-28
WO1998030590A3 (en) 1998-12-10
CN1137898C (zh) 2004-02-11
WO1998030590A9 (en) 1999-08-19
AR051906A2 (es) 2007-02-14
HUP9904596A1 (hu) 2000-06-28
KR100497709B1 (ko) 2005-06-23
DE69739912D1 (de) 2010-07-29
AU741584B2 (en) 2001-12-06
DK0948541T3 (da) 2006-07-17
KR20060030006A (ko) 2006-04-07
HK1026215A1 (en) 2000-12-08
NO993341D0 (no) 1999-07-06
PL191898B1 (pl) 2006-07-31
ATE471342T1 (de) 2010-07-15
EP0948541A2 (en) 1999-10-13
RU2198182C2 (ru) 2003-02-10
PT1645566E (pt) 2010-08-31
EP1645566A3 (en) 2006-10-11
CA2276614A1 (en) 1998-07-16
DE69735603D1 (de) 2006-05-18
JP2001508439A (ja) 2001-06-26
HUP9904596A3 (en) 2000-07-28
US5955574A (en) 1999-09-21
EP0948541B1 (en) 2006-03-29
CA2276614C (en) 2002-06-11
EP1645566A2 (en) 2006-04-12
ES2258286T3 (es) 2006-08-16
AR011517A1 (es) 2000-08-30
JP3963482B2 (ja) 2007-08-22
WO1998030590A2 (en) 1998-07-16
ATE321784T1 (de) 2006-04-15
BR9714200A (pt) 2000-03-28
AR038552A2 (es) 2005-01-19
KR20000069952A (ko) 2000-11-25
CZ301497B6 (cs) 2010-03-24
EP2206725A1 (en) 2010-07-14
IL130794A0 (en) 2001-01-28
CN1254347A (zh) 2000-05-24
SI0948541T1 (sl) 2006-06-30

Similar Documents

Publication Publication Date Title
DK1645566T3 (da) Parathyroidhormonanaloger
DE69638025D1 (de) Parathyroidhormon Analoge
NZ527053A (en) Modified amyloid precursor protein polynucleotides and polypeptides
EA199901025A1 (ru) Пептидные аналоги паратиреоидного гормона
IL210454A (en) Antibody against a new ligand of cytokine 17zcytor
BR9713294A (pt) "anticorpos contra proteìna relacionada a hormÈnio de paratiróide humano"
ATE285415T1 (de) Festphasige native chemische ligation von ungeschützten oder n-cystein-geschützten peptiden in wässrigen lösungen
TR199700714A2 (xx) Paratiroit hormonu, analoglar�n�n sentezi i�in bir y�ntem.
DK0812856T3 (da) Fremgangsmåde til fjernelse af N-terminalt methionin
DK0427863T3 (da) DNA, som koder for protein, som kan kombinere med forstærker for alfa-fetoprotein-gen
ATE432287T1 (de) Peptidfragmente mit den zelltod verhindernder aktivität
DK0923644T3 (da) G-koblet receptor, der udviser selektiv selektivitet for ATP
DK0982399T3 (da) Thyroidhormontransportörer, agonister og antagonister deraf